Related references
Note: Only part of the references are listed.Asymmetric dimethylarginine independently predicts fatal and nonfatal myocardial infarction and stroke in women - 24-year follow-up of the population study of women in Gothenburg
Tora Leong et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Dimethylarginine dimethylaminohydrolase overexpression enhances insulin sensitivity
Karsten Sydow et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Relationship of asymmetric dimethylarginine with flow-mediated dilatation in subjects with newly detected severe hypercholesterolemia
L. Vladimirova-Kitova et al.
CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING (2008)
Asymmetric dimethylarginine: a novel marker of risk and a potential target for therapy in chronic kidney disease
Jan T. Kielstein et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2008)
Effect of atorvastatin on plasma levels of asymmetric dimethylarginine in patients with non-ischaemic heart failure
Joanna M. Young et al.
EUROPEAN JOURNAL OF HEART FAILURE (2008)
Detrimental effect of oxidized LDL on endothelial arginine metabolism and transportation
Wei-Zheng Zhang et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
Selective binding of sterol regulatory element-binding protein isoforms and co-regulatory proteins to promoters for lipid metabolic genes in liver
Mary K. Bennett et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Overexpression of dimethylarginine dimethylaminohydrolase inhibits asymmetric dimethylarginine-induced endothelial dysfunction in the cerebral circulation
Hayan Dayoub et al.
STROKE (2008)
Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems
Fredrik Palm et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Statin Treatment and 3' Polyadenylation of eNOS mRNA
Ioanna Kosmidou et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Macrophage infiltration, lectin-like oxidized-LDL receptor-1, and monocyte chemoattractant protein-1 are reduced by chronic HMG-CoA reductase inhibition
Atsushi Tsuchiya et al.
CURRENT NEUROVASCULAR RESEARCH (2007)
Decreased plasma soluble RAGE in patients with hypercholesterolemia:: Effects of statins
Francesca Santilli et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
Isoform-specific regulation by NG, NG-dimethylarginine dimethylaminohydrolase of rat serum asymmetric dimethylarginine and vascular endothelium-derived relaxing factor/NO
Dan Wang et al.
CIRCULATION RESEARCH (2007)
Elevated plasma concentrations of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine predict adverse events in patients undergoing noncardiac surgery
Renke Maas et al.
CRITICAL CARE MEDICINE (2007)
Role of asymmetric dimethylarginine in vascular injury in transgenic mice overexpressing dimethylarginie dimethylaminohydrolase 2
Kazuhiro Hasegawa et al.
CIRCULATION RESEARCH (2007)
Asymmetric dimethylarginine, smoking, and risk of coronary heart disease in apparently healthy men:: Prospective analysis from the population-based Monitoring of Trends and Determinants in Cardiovascular Disease/Kooperative Gesundheitsforschung in der Region Augsburg study and experimental data
Renke Maas et al.
CLINICAL CHEMISTRY (2007)
Disruption of methylarginine metabolism impairs vascular homeostasis
James Leiper et al.
NATURE MEDICINE (2007)
Farnesoid X receptor agonist reduces serum asymmetric dimethylarginine levels through hepatic dimethylarginine dimethylaminohydrolase-1 gene regulation
Tonghuan Hu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Statins reduce macrophage inflammatory protein-1α expression in human activated monocytes
Mathias Bruegel et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2006)
Simvastatin attenuates plaque inflammation - Evaluation by fluorodeoxyglucose positron emission tomography
Nobuhiro Tahara et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression
Charles D. Searles
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2006)
Simvastatin improves diabetes-induced coronary endothelial dysfunction
Huda E. Tawfik et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Dimethylarginine dimethylaminohydrolase 2 increases vascular endothelial growth factor expression through Sp1 transcription factor in endothelial cells
Kazuhiro Hasegawa et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Early effects of simvastatin versus atorvastatin on oxidative stress and proinflammatory cytokines in hyperlipidemic subjects
ME Marketou et al.
ANGIOLOGY (2006)
Dimethylarginine dimethylaminohydrolase overexpression suppresses graft coronary artery disease
M Tanaka et al.
CIRCULATION (2005)
Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension
F Perticone et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Overexpression of dimethylarginine dimethylaminohydrolase reduces tissue asymmetric dimethylarginine levels and enhances angiogenesis
J Jacobi et al.
CIRCULATION (2005)
Pioglitazone lowers systemic asymmetric dimethylarginine by inducing dimethylarginine dimethylaminohydrolase in rats
S Wakino et al.
HYPERTENSION RESEARCH (2005)
Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis - Genetic and physiological evidence
H Dayoub et al.
CIRCULATION (2003)
Common genetic variation in a basal promoter element alters DDAH2 expression in endothelial cells
LC Jones et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase
V Achan et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Endothelial dysfunction - A marker of atherosclerotic risk
PO Bonetti et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Tiect of high-dose statin treatment on plasma concentrations of endogenous nitric oxide synthase inhibitors
H Päivä et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2003)
The liver is an important organ in the metabolism of asymmetrical dimethylarginine (ADMA)
RJ Nijveldt et al.
CLINICAL NUTRITION (2003)
Increased levels of asymmetric dimethylarginine in populations at risk for atherosclerotic disease. Effects of pravastatin
HM Eid et al.
ATHEROSCLEROSIS (2003)
Handling of asymmetrical dimethylarginine and symmetrical dimethylarginine by the rat kidney under basal conditions and during endotoxaemia
RJ Nijveldt et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2003)
Impaired nitric oxide synthase pathway in diabetes mellitus - Role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase
KY Lin et al.
CIRCULATION (2002)
all-trans-retinoic acid increases nitric oxide synthesis by endothelial cells -: A role for the induction of dimethylarginine dimethylaminohydrolase
V Achan et al.
CIRCULATION RESEARCH (2002)
Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography
T Teerlink et al.
ANALYTICAL BIOCHEMISTRY (2002)
Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease:: a prospective study
C Zoccali et al.
LANCET (2001)
Angiogenesis is impaired by hypercholesterolemia - Role of asymmetric dimethylarginine
JJ Jang et al.
CIRCULATION (2000)
Does ADMA cause endothelial dysfunction?
JP Cooke
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Chromosomal localization, gene structure, and expression pattern of DDAH1:: Comparison with DDAH2 and implications for evolutionary origins
CTL Tran et al.
GENOMICS (2000)
LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells -: Involvement of S-adenosylmethionine-dependent methyltransferases
RH Böger et al.
CIRCULATION RESEARCH (2000)
Share Paper
